earnings
AQ
NASDAQ · AQST
Aquestive Therapeutics, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$5.35
Down-$0.03 (-0.56%)
Updated Sep 4, 2026, 3:27 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 397.23M
- P/E ratio
- -6.41
- Dividend yield
- 0.00%
- 52-week range
- $2.93 – $7.55
- Volume
- 1.83M
- Avg. volume
- 4.84M
Price performance
AQST price history
1M range · 21 trading sessions · Daily adjusted prices
AQST closed at $5.35 after 21 trading sessions, up 36.48% for the selected period.
- Last close
- $5.35
- Period change
- +36.48%
- Period low
- $3.92
- Period high
- $5.39
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 3, 2026 | $5.40 | $5.44 | $5.225 | $5.35 | 1.83M |
| Sep 2, 2026 | $5.25 | $5.39 | $5.25 | $5.38 | 1.81M |
| Sep 1, 2026 | $5.15 | $5.35 | $5.09 | $5.24 | 2.17M |
| Aug 31, 2026 | $4.975 | $5.125 | $4.91 | $5.11 | 1.91M |
| Aug 28, 2026 | $5.11 | $5.18 | $4.9736 | $5.02 | 2.52M |
| Aug 27, 2026 | $5.39 | $5.395 | $5.115 | $5.16 | 3.66M |
| Aug 26, 2026 | $5.08 | $5.409 | $5.01 | $5.39 | 3.41M |
| Aug 25, 2026 | $4.77 | $5.12 | $4.72 | $5.08 | 3.67M |
| Aug 24, 2026 | $4.67 | $4.82 | $4.56 | $4.80 | 2.61M |
| Aug 21, 2026 | $4.54 | $4.72 | $4.52 | $4.66 | 2.02M |
| Aug 20, 2026 | $4.61 | $4.64 | $4.39 | $4.495 | 2.67M |
| Aug 19, 2026 | $4.31 | $4.745 | $4.31 | $4.59 | 8.42M |
| Aug 18, 2026 | $4.27 | $4.39 | $4.25 | $4.32 | 5.46M |
| Aug 17, 2026 | $4.22 | $4.35 | $4.20 | $4.29 | 3.34M |
| Aug 14, 2026 | $4.20 | $4.28 | $4.015 | $4.25 | 4.35M |
| Aug 13, 2026 | $4.25 | $4.39 | $4.14 | $4.25 | 3.75M |
| Aug 12, 2026 | $4.27 | $4.44 | $4.19 | $4.23 | 9.12M |
| Aug 11, 2026 | $4.30 | $4.69 | $4.24 | $4.41 | 6.5M |
| Aug 10, 2026 | $4.35 | $4.635 | $4.26 | $4.29 | 7.3M |
| Aug 7, 2026 | $3.95 | $4.035 | $3.865 | $3.94 | 1.86M |
| Aug 6, 2026 | $3.76 | $3.92 | $3.76 | $3.92 | 1.54M |
Latest AQST news
The latest Smart Investors Daily articles mentioning AQST.
Stock researchCompany · Financials
Loading stock research…